uniQure N.V. (QURE) jumped $6.10, or 9.4%, to $70.74 on 2.5 million shares Tuesday.  The move, on nearly 5x the stock's average volume, came on no news from the gene therapy company.  The stock, which had a steep ascent from around $28 to just under $70 in the first three months of the year, looks poised to resume the uptrend, as Tuesday's move broke it out above the March double-top.  Watch for $80-85 next.
uniQure N.V. (QURE) jumped $6.10, or 9.4%, to $70.74 on 2.5 million shares Tuesday.  The move, on nearly 5x the stock's average volume, came on no news from the gene therapy company.  The stock, which had a steep ascent from around $28 to just under $70 in the first three months of the year, looks poised to resume the uptrend, as Tuesday's move broke it out above the March double-top.  Watch for $80-85 next.
Barchart calculates a custom index (the Barchart Market Momentum Index) which is used as an indicator of overall change in the markets. The index reflects the movement of more established stocks: those with SEC filings, with 6 months of trading activity, and with price above $2.00. A high value means the market is moving up, where as a negative value implies the market is down today.